MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
31.47
-0.43 (-1.35%)
May 29, 2026, 4:00 PM EDT - Market closed
MBX Biosciences Employees
MBX Biosciences had 63 employees as of December 31, 2025. The number of employees increased by 20 or 46.51% compared to the previous year.
Employees
63
Change (1Y)
20
Growth (1Y)
46.51%
Revenue / Employee
n/a
Profits / Employee
-$1,374,730
Market Cap
1.50B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 63 | 20 | 46.51% |
| Dec 31, 2024 | 43 | 16 | 59.26% |
| Sep 30, 2024 | 38 | 11 | 40.74% |
| Jun 30, 2024 | 36 | - | - |
| Mar 31, 2024 | 28 | - | - |
| Dec 31, 2023 | 27 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Immatics | 711 |
| Immunocore Holdings | 524 |
| Ardelyx | 489 |
| KalVista Pharmaceuticals | 275 |
| Precigen | 160 |
| Innoviva | 159 |
| Maze Therapeutics | 141 |
MBX News
- 5 days ago - MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City - GlobeNewsWire
- 19 days ago - MBX Biosciences price target raised to $56 from $50 at Stifel - TheFly
- 19 days ago - MBX Biosciences price target raised to $70 from $66 at Barclays - TheFly
- 19 days ago - MBX Biosciences price target raised to $86 from $76 at Citizens - TheFly
- 20 days ago - MBX Biosciences price target raised to $70 from $50 at Truist - TheFly
- 20 days ago - MBX Biosciences Obesity Day Spotlights Monthly GLP-1 Hope and Pipeline Push - MarketBeat
- 20 days ago - MBX Biosciences Transcript: Status update - Transcripts
- 20 days ago - MBX Biosciences Press release: Status update - Filings